Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$632K Buy
2,923
+1,627
+126% +$311K 0.06% 280
2026
Q1
$238K Buy
1,296
+3
+0.2% +$553 0.03% 832
2025
Q4
$228K Sell
1,293
-234
-15% -$38.2K 0.02% 869
2025
Q3
$214K Sell
1,527
-1,852
-55% -$250K 0.02% 891
2025
Q2
$424K Buy
3,379
+818
+32% +$102K 0.05% 387
2025
Q1
$350K Buy
2,561
+56
+2% +$8.01K 0.05% 444
2024
Q4
$383K Buy
+2,505
New +$423K 0.05% 403
2023
Q3
Sell
-368
Closed -$105K 1629
2023
Q2
$105K Buy
+368
New +$110K 0.03% 820
2023
Q1
Sell
-363
Closed -$101K 1599
2022
Q4
$101K Sell
363
-550
-60% -$155K 0.03% 752
2022
Q3
$244K Buy
913
+679
+290% +$144K 0.12% 131
2022
Q2
$48K Sell
234
-950
-80% -$194K 0.03% 958
2022
Q1
$249K Sell
1,184
-145
-11% -$31.5K 0.13% 119
2021
Q4
$319K Buy
1,329
+309
+30% +$79.5K 0.15% 92
2021
Q3
$288K Sell
1,020
-47
-4% -$15.4K 0.19% 86
2021
Q2
$369K Buy
1,067
+907
+567% +$275K 0.23% 61
2021
Q1
$45K Buy
+160
New +$43.1K 0.07% 228

Other funds holding BIIB

State of Wyoming's BIIB Position: Q2 2026 in Review

State of Wyoming increased its Biogen (BIIB) stake by 126% in Q2 2026, buying an estimated $311K and bringing the position to 2,923 shares worth $632K. The position accounts for 0.06% of the portfolio, ranked #280.

State of Wyoming first reported a position in BIIB in Q1 2021 and has held it in 16 quarters since. 569 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • State of Wyoming held 2,923 shares of Biogen worth $632K as of Q2 2026.
  • State of Wyoming bought 1,627 Biogen shares in Q2 2026, an estimated $311K.
  • Biogen made up 0.06% of State of Wyoming's portfolio in Q2 2026, its #280 holding.
  • State of Wyoming first reported a position in Biogen in Q1 2021 and has held it in 16 quarters since.
  • 569 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.